Anti-CD3 antibodies and uses thereof | Patent Publication Number 20200048349
US 20200048349 A1Patent NumberUS 11603405 B2
Application Number16418082
Filled DateMay 21, 2019
Priority DateMay 24, 2018
Publication DateFeb 13, 2020
Original AssigneeJohnson & Johnson
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsJill Giles-Komar
Colleen Kane
Jennifer NEMETH-SEAY
Chichi Huang
Ronan MCDAID
Ronan McDaid
Chichi HUANG
Jennifer Nemeth-Seay
Jill GILES-KOMAR
Colleen KANE
Bradley HEIDRICH
Francois Gaudet
Francois GAUDET
Bradley Heidrich
Colleen Kane
Jennifer NEMETH-SEAY
Chichi Huang
Ronan MCDAID
Ronan McDaid
Chichi HUANG
Jennifer Nemeth-Seay
Jill GILES-KOMAR
Colleen KANE
Bradley HEIDRICH
Francois Gaudet
Francois GAUDET
Bradley Heidrich
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.